National Cancer Institute Director Andrew von Eschenbach will focus solely on his position as Food and Drug Administration commissioner.

Critics had said Von Eschenbach could not perform both jobs well, and that he could face a conflict of interest when dealing with NCI matters before the FDA

Eli Lilly and Co. will add a "black-box warning" to its attention deficit medication Strattera, saying the drug may increase suicidal thoughts among younger patients.

The move comes after the U.S. Food and Drug Administration (FDA) issued a health advisory bsaed on clinical trials conducted on the drug

Regulators are changing the look of prescription drug labels.

Rules outlining a new format will be issued soon, said Dr. Scott Gottlieb, the Food and Drug Administration deputy commissioner for medical and scientific affairs

Hector Duarte Jr. - All Headline News Staff Reporter

The company says some patients have been harmed because doctors used its Enteryx injection kit incorrectly

The U.S. Food and Drug Administration endorses expanding of the pool of people who use the popular cholesterol drug, Lipitor.

The drug is currently used to decrease the risk of strokes and heart attacks in diabetics, who also have risk factors for heart disease